Positions held by William P. Meyers

This list is to allow users of my reports, analyst conference summaries, and other services to evaluate the independence of my opinions. It is not meant as a set of recommendations. I buy stocks that I believe are undervalued, but that may be with a near-term or long-term perspective. I may hold stocks that are fairly valued or even overvalued because I do not want to pay the capital gains yet. I may hold stocks to diversify and lower aggregate risk.

My clients pay me to research stocks and bonds, with a focus on the forward-looking values of company technologies. I cannot list my client's positions, but my role is to provide an accurate, rather than a bullish, analysis of stocks. I generally do not own stocks that I research for my clients, but it has happened from time to time.

I write on a freelance basis for SeekingAlpha. Like all SeekingAlpha writers, each article discloses whether I own the stock, or other stocks mentioned in the article, at the time the article is written.

I also continue to do work for technology companies. Companies covered at this site or their business partners may occasionally be my clients. I still do occasional work for Microsoft. This site's ads are currently served up by Google. My computer models run on AMD processors.

- William P. Meyers Contact me

Also, while I try to keep this list updated, sometimes there is a lag. Bought dates are of initial purchase; I often accumulate over time and sometimes do partial sales. If there is no link, I am not posting any articles or analyst conference summaries.

 Ticker Symbol  Company
AGEN Agenus [Bought October 2013]
AGIO Agios Pharmaceuticals [Bought December 2015]
ALXN Alexion [Bought February 3, 2015]
ALNY Alnylam Pharmaceuticals [Bought October 2015]
AMAT Applied Materials [Bought March, 2008]
AMD Advanced Micro Devices [bought 2004]
AMGN Amgen [bought March 2014]
BIIB Biogen [Bought February 6, 2008]
BIVV Bioversativ [received as dividend from BIIB on 2/1/2017]
CELG Celgene [Bought June 2007]
CLDX Celldex Therapeutics [Bought September 2015]
CLSN Celsion [Bought November 2015]
EPZM Epizyme [Bought August 2015]
GILD Gilead [Bought October 2007]
GLYC Glycomimetics [bought April 2015]
IMGN Immunogen [bought May 2016]
INCY Incyte [bought 11/01/2016]
INO Inovio [bought May 2012]
JUNO Juno Therapeutics [Bought September 2015]
MACK Merrimack Pharmaceuticals [bought September 2014]
MCHP Microchip [bought 2007]
MYL Mylan [bought March 2014]
PLX Protalix Biotherapeutics [bought November, 2013]
SBLK Star Bulk Carriers [bought July 2015]
SGEN Seattle Genetics [bought February, 2015]
VBLT Vascular Biogenics [bought June 2016]
XLNX Xilinx [bought April 24, 2014]
XLRN Acceleron Pharma [bought August 2015]